Prophylactic Antibiotics in Cystectomy With Diversion

Status Recruiting

Clinical Trial Summary

Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral antibiotic, nitrofurantoin, through comparison of rates of postoperative urinary tract infections within the 90-day postoperative period in patients with muscle invasive bladder cancer who undergo radical cystectomy with urinary diversion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Ileal Conduit
Muscle-Invasive Bladder Carcinoma
Radical Cystectomy
Urinary Bladder Neoplasms

Clinical Trial Details

NCT number	NCT06190197
Study type	Interventional
Source	University of Minnesota
Contact	Maressa Twedt
Phone	612-626-6661
Email	twedt050@umn.edu
Status	Recruiting
Phase	Early Phase 1
Start date	May 13, 2024
Completion date	October 15, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05097404` - Clinical Utility of VI-RADS in Diagnosis of MIBC
Recruiting	`NCT05483868` - A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer	Phase 1
Not yet recruiting	`NCT04966130` - Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.
Active, not recruiting	`NCT04610671` - Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC	Phase 1
Recruiting	`NCT06341400` - RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients	Phase 1/Phase 2
Recruiting	`NCT05203913` - Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer	Phase 2
Recruiting	`NCT05790850` - Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)	N/A
Recruiting	`NCT05833867` - Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer	Phase 1
Recruiting	`NCT05295992` - Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach	N/A
Recruiting	`NCT06215976` - The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer	Phase 4
Recruiting	`NCT05028660` - AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study
Not yet recruiting	`NCT06417190` - Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology	Phase 2
Not yet recruiting	`NCT04909775` - Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer	Phase 2
Recruiting	`NCT04876313` - An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)	Phase 2
Not yet recruiting	`NCT04686149` - a Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients
Active, not recruiting	`NCT05630131` - ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Recruiting	`NCT06170177` - Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
Terminated	`NCT05221827` - Clinical Performance Evaluation of the C2i-Test
Recruiting	`NCT06257017` - Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: A Pilot Randomized Controlled Trial	Phase 2
Recruiting	`NCT05767528` - Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection